Answers are grounded in this paper and cite their sources.
The 72-hour supervised fasting test (72-HSFT) remains the gold standard for investigating fasting hypoglycemia in patients without diabetes, which is a rare but potentially fatal clinical condition. However, testing inaccuracies often lead to diagnostic ambiguities and unnecessary healthcare expenditures. Baseline data collection over 1 year revealed that 66% of 72-HSFT tests at our institution were performed incorrectly, with dynamic hormones such as C-peptide being ordered four times per patient. The goal of this quality improvement project (QIP) was to reduce the frequency of unnecessary or incorrect 72-HSFT for hypoglycemia from 66% to 25% within 24 months. To achieve the goals of the QIP, educational interventions targeting patients, nurses, physicians, and laboratory staff on accurate 72-HSFT were implemented. Further interventions included the introduction of an auto-text protocol in Cerner®, standardization of lab testing via a bundle order set for 72-HSFT, and multiple different models of interactive educational sessions. The project was conducted in the emergency department and the inpatient wards of the medicine department. In a plan-do-study-act 1 cycle, testing inaccuracy was reduced from 66% to 20%, with C-peptide orders reducing from 4 tests to 1.2 tests per patient. In plan-do-study-act 2, testing inaccuracy dropped to 0% with one C-peptide test ordered per patient. This QIP demonstrates that system-level changes, combined with conventional interventions such as targeted education and advanced technology-based interventions like clinical decision support tools, can significantly improve test accuracy and reduce unnecessary resource utilization in endocrinological diagnostics.
No takes yet. Share an insight, caveat, or question.
Ata et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: